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As more children and adults become obese 
in the U.S. and other countries, obesity-
associated  diseases  are  becoming  more 
prevalent worldwide (Poirier et al., 2006). 
Major chronic diseases linked to obesity 
include heart disease, stroke, and type 2 dia-
betes (Kahn et al., 2006; Poirier et al., 2006; 
Van Gaal et al., 2006). Thus, development of 
effective preventive and therapeutic strate-
gies against obesity will ultimately reduce 
the burden of cardiovascular diseases and 
diabetes. Factors contributing to obesity 
development  are  complex.  Although  it 
is obvious that human genetics plays an 
important role in determining body weight, 
it is widely accepted that the increase in the 
prevalence of obesity over the past 30 years 
cannot be attributed to changes in human 
genome so other factors are responsible for 
obesity. Recent human and mice studies 
(Reviewed in DiBaise et al., 2008; Tilg et al., 
2009) strongly support a concept that the 
gut microbiota together with host genotype 
and lifestyle contribute to the development 
of obesity. These studies suggest manipu-
lating the microbial populations in the gut 
may be one means to control body weight. 
To develop such microbiota-manipulating 
strategies to aid in weight loss, it is critical 
to identify potential keystone microorgan-
isms from more than 1,000 different species 
in the gut. However, there are three major 
limitations  in  these  pioneering  studies 
which ultimately slow progress in this field. 
First, previous studies on the relationship 
between microbiota and obesity (Ley et al., 
2005, 2006; Turnbaugh et al., 2006) only 
analyzed  fecal  samples  which  represent 
the  microbiota  from  the  large  intestine. 
However, the small intestine is the principal 
site for digestion, nutrient assimilation and 
energy harvest, which is directly relevant to 
body weight gain. In addition, the microbi-
ota have been observed to vary significantly 
between small intestine and large intestine 
(Hayashi et al., 2005; Dumonceaux et al., 
2006). Thus, use of fecal sample from small 
intestine is critical to reveal the direct rela-
tionship between gut microbiota and obes-
ity development. Second, the potential role 
of microbiota in obesity development has 
focused on the utilization of indigestible 
polysaccharides in colon. However, many 
metabolic functions of microbiota, such 
as fat digestion, are not captured by only 
considering  polysaccharide  utilization. 
For example, the deconjugation of bile salt 
complexes by bile salt hydrolases, which 
are produced by many commensal bacte-
ria (e.g., Lactobacillus), could reduce lipid 
solubilization  and  absorption  and  even 
lower cholesterol levels in humans (Begley 
et al., 2006; Ridlon et al., 2006). Lastly, due 
to technical difficulties, these studies used 
fecal biota as a surrogate for the entire gut 
microflora. However, fecal biota may not 
contain the mucosa-associated microbial 
populations that are in close contact with 
the  underlying  gut  epithelium  and  play 
a  different  but  important  role  in  nutri-
ent  assimilation  (Zoetendal  et  al.,  2002; 
Eckburg  et  al.,  2005).  Thus,  to  identify 
specific  obesity-associated  microorgan-
isms, it is essential to develop appropriate 
animal model and organ systems to over-
come the above limitations in studying the 
relationship between gut microbiota and 
human obesity.
Although  humans  are  interested  in 
manipulating microbiota to aid in weight 
loss,  the  food  animal  industry  has  been 
engaged for decades in manipulating micro-
biota to increase in weight gain through the 
use of low-dose antibiotics, usually called 
antibiotic  growth  promoters  (AGPs)  as 
feed additives (Frost and Woolcock, 1991). 
At  present,  the  precise  mechanisms  of 
growth-promoting effects of AGPs are still 
unknown. However, it is widely accepted 
that the growth-promoting effect of AGPs 
is  mediated  by  the  interaction  between 
the  AGPs  and  the  intestinal  microbiota 
(Chapman  and  Johnson,  2002;  Dibner 
and Richards, 2005) because oral antibiot-
ics do not have growth-promoting effects 
in germ-free animals (Coates et al., 1955, 
1963). Use of AGPs may change the diversity 
and structure of microbial communities in 
the animal intestine and ultimately result 
in an optimal and balanced microbiota for 
increased energy harvest capacity and better 
growth performance of food animals. Given 
that both above agricultural and human 
biomedical issues rely on the relationship 
between gut microbiota and body weight 
gain, we propose examining the effect of 
AGPs  on  intestinal  microbiota  in  food 
animals may provide an innovative model 
system  for  us  to  study  the  relationship 
between obesity and gut microbiota and 
identify  obesity-associated  microorgan-
isms. Notably, a recent human clinical study 
showed that a significant weight gain can 
occur in human after a 6-week treatment 
of vancomycin plus gentamicin for infective 
endocarditis with a risk of obesity (Thuny 
et al., 2010), which further supports our 
hypothesis to study human obesity using 
a new model system that builds on more 
than 50 years of consistent observation of 
the growth-promoting effect of AGPs on 
food animal production.
While microbiota in the intestine of food 
animals  have  been  broadly  investigated, 
very limited information is available con-
cerning the response of intestinal microbi-
ota to AGP treatment (Engberg et al., 2000; 
Knarreborg et al., 2002; Collier et al., 2003; 
Smirnov et al., 2005; Dumonceaux et al., 
2006; Guban et al., 2006; Wise and Siragusa, 
2007). With the aid of culture-  independent 
molecular approaches, the investigations on 
the effect of AGPs on intestinal microbiota 
have been initiated in poultry (Knarreborg 
et al., 2002; Dumonceaux et al., 2006; Wise 
and  Siragusa,  2007)  and  swine  (Collier 
et al., 2003). As expected, in both swine 
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microbiota was influenced by AGP treat-
ment (Knarreborg et al., 2002; Collier et al., 
2003; Dumonceaux et al., 2006; Wise and 
Siragusa,  2007).  Particularly,  lactobacilli 
populations were significantly affected by 
AGPs; AGP treatment could either reduce 
or increase the abundance of specific lacto-
bacilli species in intestine (Engberg et al., 
2000;  Knarreborg  et  al.,  2002;  Collier 
et  al.,  2003;  Dumonceaux  et  al.,  2006), 
which is consistent with the dual effects 
(beneficial  and  detrimental)  of  lactoba-
cilli on the host (Gaskins et al., 2002; Reid 
et al., 2003; Dibner and Richards, 2005; 
Heselmans  et  al.,  2005). Although  these 
findings greatly improve our understand-
ing  of  intestinal  microbiota  change  in 
response to AGPs, these studies either failed 
to show the growth-promoting effect of 
AGPs (Dumonceaux et al., 2006; Wise and 
Siragusa, 2007) or lacked any growth/nutri-
tional measurements in conjunction with 
microbial  ecology  analysis  (Knarreborg 
et  al.,  2002;  Collier  et  al.,  2003),  which 
greatly reduced the relevance of observed 
microbial structure shift to animal growth. 
The lack of a growth promotion response of 
the food animal to AGPs in previous studies 
is likely due to the use of highly sanitized 
research facility environments that limits 
the establishment of diverse microflora in 
intestine. Thus, to use food animals as a 
model for studying human obesity, it is 
critical to simulate industrial conditions 
for observation of growth promotion in an 
experimental system, consequently obtain-
ing high quality, growth-relevant intestinal 
samples for microbial ecology study using 
complementary  genomics  and  metagen-
omics approaches.
Similar  to  the  commonly  used  mice 
model,  food  animals  also  have  different 
normal  gut  microbiota  from  human  in 
terms of diversity and relative abundance, 
which  may  challenge  the  identification 
of  obesity-related  microorganisms  using 
the proposed food animal model system. 
However, intestinal microflora in humans, 
mice as well as food animals are primarily 
derived  from  the  surrounding  environ-
ment and diets. So human and food ani-
mals share many common gut microflora 
(Gong et al., 2002; Leser et al., 2002; Lu et al., 
2003; Backhed et al., 2005; Eckburg et al., 
2005; Zoetendal et al., 2006). Therefore, the 
findings from the study using the food ani-
mal model should provide insights into the 
relationship between gut microbiota and 
obesity development in humans. In addi-
tion, despite differences in the host genetic 
makeup, human and animals should share 
many common themes with respect to the 
symbiosis relationship between host and 
gut microbiota for food digestion, nutri-
ent  utilization,  and  energy  harvest  dur-
ing evolution. Thus, to better understand 
host–bacterial mutualism in the intestine, 
in addition to revealing phylogeny informa-
tion, it is essential to examine functional 
and metabolic diversity of gut microbiota 
affected by AGP usage using recently devel-
oped high-throughput approaches, such as 
metagenomic sequencing of gut microbiota 
(Turnbaugh et al., 2006) and GeoChip (He 
et al., 2010).
Among various food animals, chicken 
appears to be the most appropriate animal 
model to test our hypothesis for identify-
ing  specific  obesity-associated  microor-
ganisms due to following major reasons. 
First,  compared  to  the  previous  human 
and mice studies (Ley et al., 2005, 2006; 
Turnbaugh et al., 2006), the ease of han-
dling and the low cost of chickens provide 
obvious advantages for collecting various 
samples from different intestinal sites (e.g., 
jejunum,  ileum,  mucosa).  This  enables 
us  to  examine  microbiota  from  various 
intestinal sites and provides stronger sta-
tistical power for analyzing complex gut 
microbiota  through  greater  replication. 
Second, compared to other food animals 
(e.g., pig) that have long production cycle 
and  demanding  rearing  environment,  it 
is much easier to experimentally simulate 
poultry  industrial  conditions  and  thus 
replicate  industrial  growth  promotion, 
consequently  obtaining  growth-relevant 
intestinal samples for analysis (Waldroup 
et  al.,  2005;  Hunkapillar  et  al.,  2009). 
Finally, the chicken has been an important 
model organism in the research on human 
genetics, disease, nutrition, immunology, 
and development (Dodgson, 2003; Stern, 
2005;  Burt,  2007;  Kohonen  et  al.,  2007; 
Bahr, 2008). The high similarities between 
the  chicken  and  human  genomes  with 
respect to the genes involved in the cell’s 
basic structure and function (Hillier et al., 
2004) further supports the generalizabil-
ity of using chicken as a model organism. 
Together, examining the effect of AGPs on 
chicken gut microbiota may offer several 
significant  advantages  over  mice  as  an 
experimental system, and provide a com-
plementary alternative to identify specific 
obesity-associated microbes in humans.
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